Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Chiome Bioscience Inc. ( (JP:4583) ) has issued an update.
Chiome Bioscience Inc. reported its non-consolidated financial results for the first half of 2025, showing a decrease in net sales and continued losses compared to the previous year. The company remains focused on its Drug Discovery Support Business, with no changes to its financial forecasts, and plans to hold an explanatory meeting for institutional investors and analysts.
More about Chiome Bioscience Inc.
Chiome Bioscience Inc. operates in the biotechnology industry, focusing on drug discovery and development. The company is listed on the Tokyo Stock Exchange and provides services related to drug discovery support.
Average Trading Volume: 1,315,857
Technical Sentiment Signal: Strong Sell
Current Market Cap: Yen9.46B
For detailed information about 4583 stock, go to TipRanks’ Stock Analysis page.